The report said that women who underwent tumor excision during a phase of estrogen stimulation fared worse than those operated on during other phases of the menstrual cycle ​ — 54 percent survived ten years versus 84 percent for the latter group.
पहले समूह की स्त्रियों में ५४ प्रतिशत जबकि दूसरे समूह की स्त्रियों में ८४ प्रतिशत दस साल से अधिक जीवित रहीं ।